Heart Disease, Caution Rosiglitazone

　November 13 edition of diabetes prevention and control column in the "importance of oral hypoglycemic medication treatment effects" in the text, emphasizing the importance of the drug hypoglycemic therapy, with special emphasis on the text of rosiglitazone maleate oral long-term good single-agent control of blood sugar, is an important type Ⅱ diabetic patients safe and effective treatment option. Above formulation is indisputable, but needs to be emphasized is that the U.S. Food and Drug Administration (FDA) issued rosiglitazone maleate tablets (rosiglitazone, Avandia, TZD) medication guide reminder, Romania pioglitazone may reduce blood flow to the heart, thereby increasing the risk of heart disease, including angina or myocardial infarction onset, such as rosiglitazone and insulin or nitrates both drugs when the risks are greater, the recent there are reports in the literature of domestic rosiglitazone cause serious heart rhythm disorders, some elderly patients may have a cause mentioned in mild to moderate edema and mild anemia. Rosiglitazone, when taken with some medicines will interact lead to serious adverse reactions, including high blood sugar, low blood sugar.

As a patient taking rosiglitazone, such as the emergence of chest tightness, chest pressure or palpitation, cardiac "arrest" and so on, please seek medical assistance. Before taking the drug, the doctor should provide health conditions, such as: whether people with heart disease or heart failure, arrhythmia, diabetes, acidosis, or whether there Ι with diabetes, whether suffering from macular edema, whether pregnant or preparation for pregnancy, is suffering from liver disease, is taking an alternative treatment of diabetes troglitazone liver problems sometimes arise.
Therefore, the doctors to prescribe rosiglitazone, we must understand all the health status of patients, especially those who want to remind people with heart disease, rosiglitazone with caution.